The role of protein kinase A (PKA) in the release of amylase from permeabilized pancreatic acini was investigated.
INTRODUCTION
Pancreatic acini are stimulated to exocytose by both phospholipase C-and adenylate cyclase-linked receptors (Hootman & Williams, 1987) . Secretin and vasoactive intestinal peptide (VIP) are linked via a G-protein to adenylate cyclase. Occupancy of either the secretin or the VIP receptor leads to activation of the cyclase, generation of cyclic AMP (cAMP) and subsequent activation of protein kinase A (PKA) (Gardner & Jensen, 1986) . Both secretin and VIP have been found to elicit a small increase in amylase discharge and to potentiate secretion elicited by the phosphatidylinositol (PI)-linked agonists, cholecystokinin and acetylcholine (Schulz & Stolze, 1980) . The site at which the Pl-and cAMP-dependent pathways interact has yet to be elucidated. Although it is known that secretin and VIP can potentiate exocytosis stimulated by phorbol 12-myristate 13-acetate (PMA), the interaction of cAMP with the rise in cytosolic free [Ca2+] elicited by PI-mobilizing agonists has yet to be fully investigated. In particular, it has yet to be determined whether cAMP-mediated secretion has an absolute dependence on Ca2 .
The recent development of the permeabilized pancreatic acini allows us for the first time to manipulate independently levels of diacylglycerol, cAMP and [Ca21] -within the cell, as PI turnover does not change on stimulation with Ca2+ in the permeabilized acini (Padfield et al., 1991) . Permeabilization also allows the introduction of specific peptide inhibitors of protein kinases to determine their role in the secretory pathway of the exocrine pancreas (O'Sullivan & Jamieson, 1992) .
METHODS
Pancreatic acini were prepared by collagenase digestion of glands from starved adolescent Sprague-Dawley male rats weighing 80-100 g in buffer A [97 mM-NaCl, 5 mm-KCl, 1.2 mMMgCl2, 2 mM-CaCl2, 20 mm-glucose, 20 mM-Hepes, 0.1 mg of soybean trypsin inhibitor (SBTI)/ml, and 0.1 % BSA, pH 7.4) as previously described (Bruzzone et al., 1985) . The acini were resuspended in buffer B (139 mM-potassium glutamate, 20 mMPipes, 0.1 mg of SBTI/ml, pH 6.6) and 50 ,1 portions of acini were divided into separate tubes. An additional 150 ,u of buffer B was added on ice, containing EGTA, ATP, Ca2+, Mg2' and streptolysin-O (SLO) (permeabilization buffer) to give final concentrations of 2 mM-EGTA, 2 mM-ATP, 0.2 IU of SLO/ml, 2 mm free Mg2+ and Ca2+ to a value calculated from dissociation constants. Permeabilization was commenced by transferring the tubes to a water bath at 37°C, and amylase release was terminated by transferring the tubes to ice and centrifugation for 2 min at 2000 g. A sample of supernatant was removed to measure released amylase activity by a modification of the method of Bernfeld (1955) , as previously described (O'Sullivan & Jamieson, 1992) . Total amylase activity was determined by lysis of the acini by sonication at 50 W for 4 s on ice in buffer C containing 0.02 % Nonidet P40. Amylase release is expressed as a percentage of total amylase activity.
For experiments involving the PKI-(5-24)-peptide inhibitor, acini were permeabilized in the presence of the peptide at the non-stimulatory concentration of 10 nM-Ca2+ for 7 min before addition of the Ca2+-containing buffer. The action of H89 {N-[2-(p-bromocinnamoylamino)ethyl]-5-isoquinolinesulphonamide} was found to be affected by the reducing agent found in commercially available SLO; thus SLO was pre-bound to acini at 4°C for 10 min and washed three times in buffer B before addition of the permeabilization buffer containing H89. Pre Vol. 287 concentrations up to 10 mM slightly increased Ca2+-dependent secretion, but this increase was not significant (P. J. Padfield & J. D. Jamieson, unpublished work) . In all experiments [ATP] was kept to the more physiological concentration of 2 mm to avoid the possibility of ATP-induced artifacts.
RESULTS
Fig . 1 shows the effect of various concentrations of cAMP on amylase release elicited by a half-maximal concentration of 3/tMCa2+. Ca2+-dependent release is maximally potentiated by 3/McAMP, the EC50 being 1.7 + 0.5 /zM (mean +S.E. M., four separate cell preparations). cAMP, AMP and adenosine had no effect on release up to 10 pM (results not shown). Fig. 2 shows the effect of cAMP on the Ca2+ dose/response curve. cAMP shifts the EC50 for Ca21 from 4.7± 1.1 /tM to 3.2+ 1.0/tM (mean_S.E.M., n = 6, P = 0.002 by paired Student's t test), as has been previously observed with protein kinase C (PKC) activation by PMA under the same conditions (O'Sullivan & Jamieson, 1992) . cAMP also induces a small but significant amylase discharge at the nonstimulatory [Ca2+] of 1 ,UM, unlike PMA, which only potentiates Ca2+-dependent release. cAMP also significantly potentiated release elicited by the optimal dose of [Ca2+] . Fig. 3 shows the effect of an optimal dose of cAMP on the time of release elicited by 3 #uM-Ca2+. There is no difference in the initial phase ofrelease, but cAMP+ Ca2+ induce release over a longer period of time than does Ca2+ alone.
To determine whether the effect of cAMP on Ca2+-dependent amylase discharge was due to activation of the catalytic subunit of PKA or by some other unknown mechanism, as has been proposed for the effects of cAMP in permeabilized parotid acini (Takuma, 1988) , we attempted to inhibit the effects of cAMP with specific inhibitors of PKA. Fig. 4(a) shows the effect of increasing concentrations of the PKI-(5-24)-peptide inhibitor on release elicited by 3 /tM-cAMP in combination with 3 /tM-Ca2 .
Half-maximal inhibition of cAMP potentiation is observed at 0.48+ 0.17 /SM (mean+ S.E.M., four separate acini preparations), approx. 200-fold more than is required in vitro (Cheng et al., 1986) . Fig. 4(b) shows that this effect is specific for PKA, and that the PKI-(5-24) peptide had no effect up to 10/M on release elicited by either Ca2+ alone or in combination with PMA. We attempted to confirm these results with a second inhibitor of PKA, H89, which is competitive with respect to ATP for the kinase. To observe an effect with H89, we decreased the concentration of ATP present in the permeabilization buffer to 100 /tM (this significantly decreases Ca2+dependent release, but has no effect on the cAMP potentiation observed). Fig. 5(a) shows the effect of increasing doses of H89 on Ca2++cAMP-stimulated discharge, the IC50 for H89 being 5.3 + 1.3 1tM (mean + S.E.M., n = 4), which is approximately one-tenth of the K, observed in vitro for PKC, myosin light-chain kinase, CAMkinase II and casein kinases (Chijiwa et al., 1990) . Fig. 5(b) shows that H89 had no effect on discharge elicited by Ca2+ alone or by Ca2+ +PMA.
Given the effects of the PKA inhibitors on Ca2++PMA-induced release, and the similarity of the effects of PKA and PKC activation on Ca2+-dependent discharge, we investigated the effects of simultaneous PKA and PKC activation on amylase release. Sub-stimulatory doses of 1 4aM-cAMP and 30 nM-PMA synergize in the presence of 3 /tM-Ca2+ to elicit a 75% increase in amylase release above that caused by 3 ,/M-Ca2+alone (P < 0.02 by Mann-Whitney U-test). This effect is entirely dependent on the presence of stimulatory concentrations of Ca2+ and is not observed to occur at 10 nM-Ca2+ (results not shown). To determine whether PKA and PKC are acting through an identical mechanism to potentiate Ca2+-dependent discharge, we investigated the effect of varying the concentration of PMA in the presence of 3 /sM-Ca2+ and the optimal concentration of cAMP. Fig. 6 shows that the effect of PMA is additive with that of cAMP, implying that at least part of the effect of the two kinases is due to separate effector mechanisms.
DISCUSSION
The data in this paper show that cAMP potentiates release of amylase from permeabilized rat pancreatic acini cells, elicited by both Ca2l and PKC. Previous studies in permeabilized acini have reported similar effects, but at much higher concentrations of cAMP (Kitagawa et al., 1991) . Those investigators also failed to show whether the effects of cAMP were due to activation of PKA. We have shown that the actions of cAMP on amylase release can be inhibited by two specific inhibitors of the catalytic subunit of PKA. In addition, the KCl-based buffers used in previous studies have raised questions about the possibility of second-messenger-activated Cl--dependent granule lysis (O'Sullivan & Jamieson, 1992) .
It has been proposed that cAMP-mediated exocytosis in the closely related parotid acinar cell is due to the actions of the regulatory rather than the catalytic subunit of PKA (Takuma, Paramecium (Zieseniss & Plattner, 1985) , adrenal chromaffin cells (Holz et al., 1989) and pancreatic acini (J. D. Jamieson & P. J. Padfield, unpublished work). The effects of PKA activation are very similar to those of PKC activation. Both potentiate Ca2+-dependent release, shifting the curve for Ca2+-dependence of discharge leftwards and increasing the time over which the cells release. This similarity of effect is reflected in the fact that cAMP and PMA synergize at suboptimal doses. One possible cause of this synergism is that the two kinases act on an identical substrate, which subsequently mediates the effect on discharge. This hypothesis is supported by the finding in intact cells that a small number of proteins are phosphorylated in response to both cAMP and PI-mobilizing agonists, and this phosphorylation is synergistic under combined stimulation (Ederveen et al., 1989) .
The major difference between PKA and PKC activation is that PKA activation causes amylase release at non-stimulatory [Ca2+], where PKC activation has no effect on amylase release. However, there is an absolute Ca2+-dependence for the effect of PKA activation on amylase release, as cAMP-dependent release is abolished at 10 nM-Cal+. This appears to reflect a requirement of the exocytotic machinery rather than a requirement for phosphorylation, as PKA is active in vitro in the absence of Ca2 .
Both H89 (3 out of 8 acini preparations) and the PKI-(5-24)-peptide inhibitor (1 out of 5 acini preparations) were found to inhibit PMA-potentiated release intermittently. This may be due to residual cAMP in the permeabilized acini, below a concentration to affect amylase release in the presence of Ca2+. The residual cAMP could synergize with PMA, resulting in an apparent inhibition of Ca2+/PKC-mediated release in the presence of either H89 or the PKI-(5-24)-peptide.
Further studies are needed to determine the substrates of PKA and PKC in permeabilized rat pancreatic acini.
